Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > the grace period
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(200)
•••
Comment by rad10on Oct 20, 2017 12:06pm
166 Views
Post# 26837020

RE:RE:RE:RE:the grace period

RE:RE:RE:RE:the grace period
Evenstephen wrote: company will have lower interest payments, and start keeping some of its cash. Bk priced into common shares. Shares will rise when debt is renegotiated. Company still makes a lot of money, just not enough for the debt they carry. You will see. Goodbye until agreement is reached. Please don't respond I don't care what you think. This goes for the rest of the shorters as well. Let's just wait and see. Thank you.


Bagholder platinum
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities